GSAM unveils portfolio investing in healthcare companies at 'forefront' of innovation

Four key investment areas including genomics and digitisation

Goldman Sachs Asset Management (GSAM) has launched a new portfolio that will provide exposure to global companies at the "forefront" of healthcare innovation, with a focus on genomics, precision medicine, minimally invasive procedures and digitisation.

The Goldman Sachs Global Future Health Care Equity Portfolio, a new sub-fund of the UCITS-qualifying Luxembourg-domiciled Goldman Sachs Funds SICAV, will be managed by GSAM's 80-person fundamental equity team with the intention to generate superior long-term returns for investors. Luke Barrs, head of GSAM fundamental equity client portfolio management in EMEA, said: "Innovation in healthcare had already brought the global industry to an inflection point, but the pandemic has supercharged an existing secular trend, and pushed healthcare right to the top of governments' and societies' prio...